However, when the kidneys are no longer working—referred to as kidney failure—urea can accumulate to toxic levels. Uremia is most often due to kidney failure from advanced chronic kidney ...
Patients with uremia secondary to chronic kidney disease will generally require EPO replacement therapy for treatment or prevention of anemia; recombinant human EPO is, therefore, already a ...
The study centered on the condition experienced during kidney disease called uremia—the accumulation of toxic metabolites in the body in the absence of kidney filtration of the blood.
Treatments for uremic bleeding target the various factors that seem to have a role in platelet dysfunction. Interventions can exert acute (within 6 h) or delayed (within several weeks) effects ...